Subcutaneous Biologics Market: Moving Towards a Brighter Future
Biologic, also known as biopharmaceutical, is a complex medicinal product manufactured by a biological process. Examples of biologics include blood and plasma derived products, vaccines, somatic cells and body proteins. Biologics market refers to a multibillion dollar opportunity that is expanding globally at an impressive growth rate. Most biologic products are given intravenously. However, in the past few years, a number of biologics have been developed that are given subcutaneously. The subcutaneous route of administration offers significant advantages over intravenous administration such as ease of drug administration, does not require skilled personnel for drug administration, enables at-home drug delivery and thus reduces patient time at healthcare facilities, reduced medicine cost and increased therapy compliance. Owing to aforementioned factors, the subcutaneous route of administration has gained enormous traction in recent years. Subcutaneous route of drug administration are highly effective in administering biologics such as vaccines, proteins, peptides, antibodies and other large and complex molecules.
To understand Research Methodology, please click: https://www.coherentmarketinsights.com/insight/request-sample/74
Increase in Awareness and the number of Diagnosed cases will Drive Demand in Developing Regions
In terms of geography, the global market for subcutaneous biologics is segmented into four major regions, namely, North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). There is huge healthcare spending in countries such as United States and Canada, and high prevalence of diseases such as rheumatoid arthritis and breast cancer. The Centers for Disease Control and Prevention (CDC) estimate that the current prevalence of rheumatoid arthritis (nearly 50 million Americans in 2012) will increase to 78 million by 2040. The disease also affects nearly 300,000 children in the U.S. according to RheumatoidArthritis.org. In the European region, EU-5 countries (Germany, France, United Kingdom, Italy and Spain) are the most potential market owing well established economy of these regions. Convenient drug delivery format is also in demand in developing regions such as Asia Pacific and Latin America where therapy compliance is a major issue. Large undiagnosed population, inadequate access to medicines and affordability issues hinder the market growth for subcutaneous biologics in developing regions.
The global market for subcutaneous biologics will be expanding under the influence of factors such as:
Advantages over other routes of administration
Increasing trend of self-medication
Introduction of innovative drug delivery devices such as auto-injectors and prefilled syringes
Growing incidence and prevalence of rheumatoid arthritis and breast cancer
Growth in the biosimilars market
Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/74
Some of the major companies operating in the global subcutaneous biologics market include Genentech Inc., Biogen Idec, F. Hoffmann-La Roche AG, Amgen, Inc., Eisai, Inc., AbbVie, Inc., Pfizer Ltd., Takeda Pharmaceutical Company Ltd. and Bristol-Myers Squibb.
You may be interested
Adipic Acid Market Analysis by Current Market Scenario And Future Prospects 2017-2025Sayali Tribhuvan - July 19, 2018
Adipic Acid or Hexanedioic Acid are organic compounds with molecular formula (CH2)4(COOH)2. Adipic acids are commercially formed by the reaction between cyclohexanone and cyclohexanol. High purity adipic…
Food Allergy and Intolerance Products Industry Growth Analysis and Futuristic Opportunities Till 2026Sayali Tribhuvan - July 18, 2018
Food allergy is caused due to consumption of particular food which stimulates unusual reaction in the immune system of the human body. Food tolerance is caused due…
Global Wearable Computing Devices Market predicts rise in demand by 2026Sayali Tribhuvan - July 18, 2018
Global Wearable Computing Devices Market Research Study provide detailed information about the key factors influencing the growth of the industry which include drivers, restraints, opportunities, and industry-specific…